• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

KCL: Chronic fatigue syndrome. (treatment review) Sept 2015

WillowJ

คภภเє ɠรค๓թєl
Messages
4,940
Location
WA, USA
https://www.ncbi.nlm.nih.gov/pubmed/26415100

BMJ Clin Evid.
2015 Sep 28;2015. pii: 1101.
Chronic fatigue syndrome.
Cleare AJ1, Reid S, Chalder T, Hotopf M, Wessely S.
Author information
  • 1King's College London, Institute of Psychiatry, Psychology and Neuroscience, Centre for Affective Disorders, Department of Psychological Medicine, London, UK.
Abstract
INTRODUCTION:
Chronic fatigue syndrome affects between 0.006% and 3% of the population depending on the criteria of definition used, with women being at higher risk than men.

METHODS AND OUTCOMES:
We conducted a systematic overview, aiming to answer the following clinical question: What are the effects of selected treatments for chronic fatigue syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to November 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review).

RESULTS:
At this update, searching of electronic databases retrieved 169 studies. After deduplication and removal of conference abstracts, 86 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 71 studies and the further review of 15 full publications. Of the 15 full articles evaluated, two systematic reviews, one RCT, and one further follow-up report of an RCT were added at this update. We performed a GRADE evaluation for 23 PICO combinations.

CONCLUSIONS:
In this systematic overview, we categorised the effectiveness of four interventions based on information relating to the effectiveness and safety of antidepressants, cognitive behavioural therapy, corticosteroids, and graded exercise therapy.
 

ScottTriGuy

Stop the harm. Start the research and treatment.
Messages
1,402
Location
Toronto, Canada
Has any one informed BMJ Clin Evid that they have published Wessely bullshit and should retract it to try to protect their journal's reputation which is in now if free fall?

Peer reviewed? Evidently not.
 

Simon

Senior Member
Messages
3,789
Location
Monmouth, UK
BMJ Clin Evid. 2015 Sep 28;2015. pii: 1101.
Chronic fatigue syndrome.
Cleare AJ1, Reid S, Chalder T, Hotopf M, Wessely S.
Curious, Simon Wessley is on record as saying he's retired from the field.
They've had a review on the BMJ sites for years, possibly over a decade. This is presumably an update.
Ah, maybe that explains it

CONCLUSIONS:
In this systematic overview, we categorised the effectiveness of four interventions based on information relating to the effectiveness and safety of antidepressants, cognitive behavioural therapy, corticosteroids, and graded exercise therapy.
A little strange the conclusions (and results) report no conclusions or results: "We did a study".
I thought there were guidelines on informative abstracts, so people can make some evaluation without paying for the full text.
 
Last edited:

halcyon

Senior Member
Messages
2,482
Guess they didn't think much of the recent AHRQ review so they had to do their own? Will be interesting to see how the conclusions differ.
 
Messages
5,238
Location
Sofa, UK
Curious, Simon Wessley is on record as saying he's retired from the field.


A little strange the conclusions (and results) report no conclusions or results: "We did a study".
I thought there were guidelines on informative abstracts, so people can make some evaluation without paying for the full text.
Although I think we can quite reliably guess what their conclusions were...somewhat foregone?